Israeli medical cannabis firm InterCure plans Nasdaq listing
05 Dec Israeli medical cannabis firm InterCure plans Nasdaq listing
Posted at 12:37h
in
News
by KMFSLLP
Israel’s InterCure,
which recently entered the medical cannabis market, plans to
list on Nasdaq by mid-2019, its controlling shareholder, Alex
Rabinovitch, said on Thursday.
Sorry, the comment form is closed at this time.